Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The variability of MCID, SCB, PASS, and MOI thresholds for PROMs in the reverse total shoulder arthroplasty literature: a systematic review.
Yendluri A, Alexanian A, Lee AC, Megafu MN, Levine WN, Parsons BO, Kelly JD 4th, Parisien RL; Investigation performed by the Scientific Collaborative for Orthopedic Research and Education (SCORE) Group. Yendluri A, et al. Among authors: alexanian a. J Shoulder Elbow Surg. 2024 Oct;33(10):2320-2332. doi: 10.1016/j.jse.2024.03.051. Epub 2024 May 15. J Shoulder Elbow Surg. 2024. PMID: 38754543
Identifying and Addressing Barriers to Implementing Core Electronic Health Record Use Metrics for Ambulatory Care: Virtual Consensus Conference Proceedings.
Levy DR, Moy AJ, Apathy N, Adler-Milstein J, Rotenstein L, Nath B, Rosenbloom ST, Kannampallil T, Mishuris RG, Alexanian A, Sieja A, Hribar MR, Patel JS, Sinsky CA, Melnick ER. Levy DR, et al. Among authors: alexanian a. Appl Clin Inform. 2023 Oct;14(5):944-950. doi: 10.1055/a-2187-3243. Epub 2023 Oct 6. Appl Clin Inform. 2023. PMID: 37802122 Free PMC article.
Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibiting moderate effect on normal stem cells growth.
Alexanian A, Stoellinger H, De Araujo Farias V, Quinones-Hinojosa A. Alexanian A, et al. Res Sq [Preprint]. 2023 Mar 20:rs.3.rs-2698139. doi: 10.21203/rs.3.rs-2698139/v1. Res Sq. 2023. Update in: Invest New Drugs. 2023 Jun;41(3):371-375. doi: 10.1007/s10637-023-01370-7 PMID: 36993520 Free PMC article. Updated. Preprint.
56 results